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Abstract
Traditional genome-wide scans for positive selection have mainly uncovered selective sweeps
associated with monogenic traits. While selection on quantitative traits is much more common,
very few signals have been detected because of their polygenic nature. We searched for posi-
tive selection signals underlying coronary artery disease (CAD) in worldwide populations, using
novel approaches to quantify relationships between polygenic selection signals and CAD
genetic risk. We identified new candidate adaptive loci that appear to have been directly modi-
fied by disease pressures given their significant associations with CAD genetic risk. These can-
didates were all uniquely and consistently associated with many different male and female
reproductive traits suggesting selection may have also targeted these because of their direct
effects on fitness. We found that CAD loci are significantly enriched for lifetime reproductive
success relative to the rest of the human genome, with evidence that the relationship between
CAD and lifetime reproductive success is antagonistic. This supports the presence of antago-
nistic-pleiotropic tradeoffs on CAD loci and provides a novel explanation for the maintenance
and high prevalence of CAD in modern humans. Lastly, we found that positive selection more
often targeted CAD gene regulatory variants using HapMap3 lymphoblastoid cell lines, which
further highlights the unique biological significance of candidate adaptive loci underlying CAD.
Our study provides a novel approach for detecting selection on polygenic traits and evidence
that modern human genomes have evolved in response to CAD-induced selection pressures
and other early-life traits sharing pleiotropic links with CAD.
Author summary
How genetic variation contributes to disease is complex, especially for those such as coronary
artery disease (CAD) that develop over the lifetime of individuals. One of the fundamental
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questions about CAD––whose progression begins in young adults with arterial plaque accu-
mulation leading to life-threatening outcomes later in life––is why natural selection has not
removed or reduced this costly disease. It is the leading cause of death worldwide and has
been present in human populations for thousands of years, implying considerable pressures
that natural selection should have operated on. Our study provides new evidence that genes
underlying CAD have recently been modified by natural selection and that these same genes
uniquely and extensively contribute to human reproduction, which suggests that natural
selection may have maintained genetic variation contributing to CAD because of its benefi-
cial effects on fitness. This study provides novel evidence that CAD has been maintained in
modern humans as a by-product of the fitness advantages those genes provide early in
human lifecycles.
Introduction
It is well established that modern human traits are a product of past evolutionary forces that
have shaped heritable variation, but we are far from a good understanding of whether recent
natural selection has acted on these and how this process has left its imprint across the genome.
While many genome-wide multi-population scans have searched for signatures of positive selec-
tion [1–9], these studies have detected relatively few adaptive candidates for common traits or
diseases [10–12]. This suggests that classic ‘selective sweeps’ have been relatively rare in recent
human history [13–16] and that current tools may not be appropriate for detecting and validat-
ing smaller shifts in adaptive variation, thus limiting our understanding of how natural selection
acts on common diseases and traits [12]. Research in this area is also important as the combina-
tion of positive selection and significant GWAS signals at the same locus supports the existence
of functional variation for disease. Here, we aimed to comprehensively identify selection signals
for coronary artery disease (CAD) loci with methods designed to detect recent signals of positive
selection. We compared selection signals in 12 worldwide populations (HapMap3) with CAD
genetic risk (CARDIoGRAMplusC4D) to help understand how selection acts on disease varia-
tion at the genetic level and prioritize genes most likely modified in relation to CAD. We ex-
amined the association between selection signals and gene expression to further test whether
adaptive candidates are functionally important for CAD in terms of gene regulation. Lastly, we
tested if CAD genes are associated with reproductive fitness to try to understand why this com-
mon disease persists in modern humans.
Classic population genetics theory describes positive selection with the selective-sweep (or
hard-sweep) model, in which a strongly advantageous mutation increases rapidly in frequency
(often to fixation) resulting in reduced heterozygosity of nearby neutral polymorphisms due to
genetic hitch-hiking [17, 18] and a longer haplotype with higher frequency. Many methods
have been developed to detect these signatures [19, 20], including traditional tests that detect
differentiation in allele frequencies among populations (i.e. Wright’s fixation index, Fst [21])
and more recently developed within population tests for extended haplotype homozygosity
(i.e. integrated haplotype score, iHS [9]). Some of the most convincing examples of human
adaptive evolution have been uncovered for traits influenced by single loci with large effects.
For example, the lactase persistence (LCT) and Duffy-null (DARC) mutations affecting expres-
sion of key proteins in milk digestion [10] and malarial resistance [22] both display hallmarks
of selective sweeps. Other loci that are not clearly monogenic but also show selective sweeps
are associated with high-altitude tolerance (EPAS1 [23]) and skin pigmentation (SLC24A5 and
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KITLG [24]). These studies show that rapid selective sweeps mainly occurred for new muta-
tions with large effects on phenotypes.
Motivated by these initial successes and the increasing availability of global population data
genotyped on higher resolution arrays (i.e. HapMap Project, 1000 Genomes Project), many
recent genome-wide scans for candidate adaptive loci have recently been performed [11].
These suggest that selection may have operated on a variety of biological processes [10] in
ways that differ among populations (i.e. local adaptation) [25], been prevalent in genetic
variation linked to metabolic processes [26], and may often target intergenic regions and gene
regulatory variants rather than protein-coding regions [12]. Often only the larger signals
underlying monogenic (or near-monogenic) traits are typically considered for follow-up
because of losses in the statistical power needed to quantify significance for smaller candidate
adaptive signals after correcting for genome-wide multiple testing [20]. The adaptive status
of many smaller candidate signals also remains uncertain due to inconsistencies in results
between studies that utilized the same data [14], and it is inherently more difficult to function-
ally validate candidate adaptive signals underlying complex polygenic traits compared to
monogenic traits where only one or a few variants may have been under selection due to their
influence on fitness [27, 28].
In contrast to population genetics, research in quantitative genetics has shown that rapid
adaptation can often occur on complex traits that are highly polygenic [29, 30]. Under the
‘infinitesimal (polygenic) model’, such traits are likely to respond quickly to changing selective
pressures through smaller allele frequency shifts in many polymorphisms already present in
the population [13, 31]. Selection on such variation is generally less likely to push it towards
fixation due to genetic correlations, thus producing smaller changes in surrounding heterozy-
gosity over time that are harder to detect with most current population genetic methods [14,
28, 32]. Note that polygenic and classic sweep models are not mutually exclusive [13, 33], for
alleles with small- and large-effects may both underlie a polygenic trait, which suggests that
there will be some variation in the degree to which candidate alleles are modified after selective
events. Because most common diseases are highly polygenic, we need to improve how we
detect and classify the adaptive signatures underlying these traits.
Recent studies investigating genomic selection on polygenic traits have taken two ap-
proaches. The first scans for significant selection signals for a subset of large effect SNPs that
have previously been identified as genome-wide significant. For example, Ding and Kullo [34]
found significant population differentiation (Fst) for 8 of 158 index SNPs underlying 36 car-
diovascular disease phenotypes, and Raj et al. [35] observed elevated positive selection scores
(Fst, iHS) for 37 of 416 index susceptibility SNPs underlying 10 inflammatory-diseases. The
second approach tests if aggregated shifts in genome-wide significant allele frequencies are
associated with phenotypic differences by population, latitudinal, or environmental gradients,
which might indicate local adaptation. For example, Castro and Feldman [36] used 1300 index
SNPs underlying many polygenic traits and found elevated adaptive signals (Fst and iHS)
above background variation, and Turchin et al. [37] demonstrated moderately higher fre-
quency of 139 height-increasing alleles in a Northern (taller) compared to Southern (shorter)
European populations. These approaches all assume that genome-wide significant variants are
the most probable selection targets, but many if not most such variants are tags for the causal
variants, which may be at lower frequencies. This suggests an approach more sensitive for
detecting subtle signals of polygenic selection is needed.
We chose CAD as a model for examining polygenic selection signals for complex disease
because it has (and continues to) impose considerable disease burden (and possible selection
pressure) in humans [38], its underlying genetic architecture has been extensively studied [39,
40] and many of its risk factors (cholesterol, blood pressure) have been under recent natural
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selection [41] related to potential pleiotropic effects or tradeoffs with CAD. Antagonistic
pleiotropy describes gene effects on multiple linked traits where selection on one may cause
negative fitness effects (i.e. reproduction, survival, and disease) in the other due to their antag-
onistic genetic association [42]. Two common misconceptions are that CAD only occurs in
older people and is a disease that has mainly afflicted modern humans. If either were true,
selection might not have had either the opportunity or sufficient time to affect genetic varia-
tion associated with CAD. However, CAD begins to manifest during reproductive ages [43,
44] and disease origins can be detected even in adolescence through degree of atherosclerosis
[44, 45] and myocardial infarction events [46]. CAD is also a product of many heritable risk
factors (cholesterol, weight, blood pressure) whose variation is expressed during the reproduc-
tive period, when CAD could drive selection directly or indirectly. Furthermore, CAD has
impacted human populations since at least the ancient Middle Kingdom period, with athero-
sclerosis detectable in Egyptian mummies [47]. This suggests that there has been enough time
for evolutionary responses to CAD to have occurred, genomic signatures from which may be
detectable in modern humans.
By combining several 1000 Genomes-imputed datasets including HapMap3 and Finnish
SNP data, a large genetic meta-analysis of CAD, HapMap3 gene expression data and lifetime
fitness data from the Framingham Heart Study, we sought to address the reason(s) why CAD
exists in humans by answering the following questions: 1) Has selection recently operated on
CAD loci? 2) How do selection signals underlying CAD loci vary among populations and are
they enriched for gene regulatory effects? 3) Do candidate adaptive signatures overlap directly
with CAD genetic risk and is this useful for highlighting disease-linked selection signals? 4) Do
CAD-linked selection signals display functional effects and evidence of antagonistic pleiot-
ropy, in that they are also linked to biological processes or traits influencing reproduction?
Results
To test for selection signals for variants directly linked with CAD, we utilized SNP summary
statistics from 56 genome-wide significant CAD loci in Nikpay et al. [40], the most recent and
largest CAD case-control GWAS meta-analysis to date, to identify 76 candidate genes for
CAD (see Methods). Nikpay used 60,801 CAD cases and 123,504 controls from a mix of indi-
viduals of mainly European (77%), south (13% India and Pakistan) and east (6% China and
Korea) Asian, Hispanic and African American (~4%) descent with genetic variation imputed
to a high-density using the 1000 Genomes reference panel. By investigating all SNPs in CAD
genes, we aimed to improve detection of smaller polygenic selection signals for the range of
functional genic variants and short-range intergenic regulatory variants that would be missed
with approaches that only consider genome-wide significant SNPs.
Signals of positive selection within coronary artery disease loci
We utilised the integrated Haplotype Score (iHS) to estimate positive selection for each SNP
underlying CAD genes within each population separately. Because iHS is typically used to
detect candidate adaptive SNPs where the selected alleles may not have reached fixation [9],
this estimate is well suited for detecting recent signals of selection as opposed to other mea-
sures [20]. iHS is also better suited for detecting selection acting on standing variation in poly-
genic traits [20, 48].
Candidate selection signals were found for many of the 76 CAD genes within each of the 12
worldwide populations (11 HapMap3 populations and Finns; Fig 1A for top 40 based on their
association with CAD log odds genetic risk, S1 Fig for all 76). These were defined as ‘peaks’ of
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significantly elevated iHS scores across SNPs within each gene-population combination, with
the apex approximating the likely positional target of positive selection.
The results for the largest iHS score per gene and population (Fig 1A) show that most can-
didate selection signals were relatively small, but a few larger signals were detected. For exam-
ple, out of the 912 gene-by-population combinations (S1 Fig), 354 (38%) contained weak-
moderate candidate selection signals (significant iHS between 2–3), 84 (9%) contained moder-
ate-strong signals (significant iHS between 3–4), and 6 (0.6%) had very strong signals (signifi-
cant iHS> 4). The 6 largest candidate signals were found in the following gene-population
combinations: BCAS3 in GIH (iHS = 4.45), MEX (iHS = 4.23) and CEU (iHS = 4.86), PEMT in
MKK (iHS = 4.24), ANKS1A in LWK (iHS = 4.03), and CXCL12 in JPT (iHS = 4.10), with all
iHS p values<0.0001. Six genes (BCAS3, SMG6, PDGFD, KSR2, SMAD3, HDAC9) exhibited
Fig 1. Association of coronary artery disease (CAD) genetic risk and positive signatures of selection in 12 worldwide populations.
The 40 of 76 CAD genes investigated are shown that have at least four significant selection-risk associations in Panel B across all 12
populations. Panel A. Magnitude and significance of largest positive selection signal (integrated haplotype score, iHS) within each gene-
population combination. P values (circles within squares) were obtained from 10000 permutations. Bonferroni corrected p value limit also shown
(α = 0.05/76 = 0.000657) with closed circles. Panel B. Null hypothesis: no association between CAD genetic risk and positive selection, tested
using mixed effects model with SNP estimates of CAD log odds genetic risk and iHS while accounting for gene LD structure as a random effect
(first eigenvector from LD matrix per gene). Scaled regression coefficients were obtained directly from regressions, each p value from 10000
permutations. Panel C. Null hypothesis: association between genetic risk and positive selection for SNPs within CAD genes no different than
non-CAD associated genes. Permuted p values were estimated by comparing each p value in Panel B against 100 nominal p values obtained by
randomly choosing (without replacement) 100 non-CAD associated genes of similar size across the genome and using the same mixed effects
model setup as described above. Populations. Grouped by ancestry, African (ASW, African ancestry in Southwest USA; MKK, Maasai in
Kinyawa, Kenya; YRI, Yoruba from Ibadan, Nigeria; LWK, Luhya in Webuye, Kenya), East-Asian (CHB, Han Chinese subjects from Beijing;
CHD, Chinese in Metropolitan Denver, Colorado; JPT, Japanese subjects from Tokyo), European (CEU, Utah residents with ancestry from
northern and western Europe from the CEPH collection; TSI, Tuscans in Italy; FIN, Finnish in Finland), GIH (Gujarati Indians in Houston, TX,
USA), MEX (Mexican ancestry in Los Angeles, CA, USA).
https://doi.org/10.1371/journal.pgen.1006328.g001
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candidate selection signals consistently within all populations (Fig 1A), and many genes also
contained consistent selection signals for all populations within similar ancestral groups (e.g.
African, European etc, Fig 1A).
Within CAD genes, multiple candidate selection signals were sometimes present (particu-
larly within larger genes, within separate linkage disequilibrium (LD)-blocks); these varied
between and sometimes within a population. For example, eleven (of the twelve) populations
had candidate selection signals in PHACTR1 introns 4, 7 or 11 (Table 1; see also S2 Fig, com-
paring cross-population selection signals in PHACTR1) that were in separate LD-blocks (see
S2 Fig, LD plots). For eight populations, there was a broad and relatively weak set of candidate
selection signals in intron 4 (the largest PHACTR1 intron, ~300kb in length). Intron 4 is also
the location of the published CAD index SNP (rs12526453) for PHACTR1. Other interesting
candidate selection signals present in other CAD genes (S1 Fig) are not discussed here. Such
patterns suggest that candidate selection signals are sometimes complex and often do not cor-
respond to the SNPs with largest effect on disease.
Relationship between CAD genetic risk and selection across populations
For each CAD gene within each population, we used a mixed effects linear model to regress
SNP-based estimates of CAD log odds genetic risk (ln(OR), obtained from cardiogramplus
c4d.org) against iHS selection scores (see Methods). We accounted for LD structure by includ-
ing the first eigenvector from an LD matrix of correlations (r2) between SNPs within each gene
as a random effect.
For a subset of CAD loci, we found significant quantitative associations between disease
risk and selection signals and for each of these the direction of this association was often con-
sistent between populations (Fig 1B). Furthermore, when compared to a null distribution of
genes selected randomly from the genome, the strength of the CAD log odds versus selection
signal at most loci was statistically significant (Fig 1C). Fig 1B shows 40 genes ranked based on
those with the most consistent number of significant associations across the 12 populations,
with those that showed fewer than four significant associations excluded. Positive and negative
associations indicate elevated selection signals present in regions with higher or lower CAD
log odds genetic risk, respectively.
In the comparison across populations, directionality of significant selection-risk associa-
tions tended to be most consistent for populations within the same ancestral group (Fig 1B).
For example, in PHACTR1, negative associations were present within all European populations
Table 1. Leading multiple candidate selection signals in PHACTR1 SNPs.
rs2015764 rs4142300 rs8180558 rs4715043 rs6924689
12788283 bp 12825772 bp 12919989 bp 12987641 bp 13025819 bp
MEX, 2.08* GIH, 3.73*** ASW, 2.43** LWK, 2.75** YRI, 2.17* CHB, 2.26* CHD, 2.89** JPT, 3.00**
rs4273688—rs11760186 rs9349549
13192799–13196011 bp, intron 7 13277029 bp, intron 11
ASW, 2.38** LWK, 2.00* MKK, 2.95** CHD, 2.05* GIH, 2.13* MKK, 2.91** CEU, 2.71** TSI, 2.96**
Values include SNP rsID, build 37 base pair chromosomal position, population, absolute integrated Haplotype Score |iHS| and permuted p values (*p<0.05;
**p<0.01; ***p<0.001).
Populations: ASW (African ancestry in Southwest USA), MKK (Maasai in Kinyawa, Kenya), YRI (Yoruba from Ibadan, Nigeria), LWK (Luhya in Webuye,
Kenya), CHB (Han Chinese subjects from Beijing), CHD (Chinese in Metropolitan Denver, Colorado), JPT (Japanese subjects from Tokyo), CEU (Utah
residents with ancestry from northern and western Europe from the CEPH collection), TSI (Tuscans in Italy), GIH (Gujarati Indians in Houston, TX, USA),
MEX (Mexican ancestry in Los Angeles, CA, USA).
https://doi.org/10.1371/journal.pgen.1006328.t001
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(CEU, TSI, FIN), and in NT5C2 strong positive associations were present in all East Asian pop-
ulations (CHB, CHD, JPT). Other negative associations that were consistent across all popula-
tions within an ancestry group included five genes in Europeans (COG5,ABO,ANKS1A,
KSR2, FLT1) and four genes (LDLR, PEMT, KIAA1462, PDGFD) in East Asians.
Additional consistent positive associations included four genes (CNNM2, TEX41,NT5C2,
MIA3) in East Asians, three (BCAS3, RAI1,KCNK5) in Europeans, and one (PPAP2B) in Afri-
cans. In comparison to other ancestral groups, African populations showed fewer significant
selection-risk associations (27.9% of all 76-gene x 12-population combinations) than Asians
(31.5%) or Europeans (32.8%). Some associations were consistent in all but one population
(e.g. CNNM2, ABCG8 in Europeans; BCAS3, KCNK5 in Asians; CNNM2, TEX41 in Africans)
or unique to one population within an ancestral group (e.g. TEX41 in FIN, COG5 in ASW).
Below we focus on BCAS3 (Fig 2) and PHACTR1 (Fig 3), two of the strongest selection-risk
associations which, when adjusting for LD (see Methods), displayed varying directionality
between at least two populations.
Fig 2. Quantitative links between coronary artery disease risk and selection signals in BCAS3. A.
Correlation between selection signals (iHS) and coronary artery disease (CAD) log odds genetic risk (log odds, ln
(OR)), both represented as absolute values. Red line/upper right value, β from mixed effects regression. B. Base
pair positional comparison of selection signals and CAD genetic risk across BCAS3. Blue points, CAD log odds
values; grey-orange or non-significant-significant points, iHS scores. Horizontal bar shows BCAS3 gene (and
intron) span and location of lead index SNP. Blue/orange lines are smoothed lines estimated with loess function in
R. C. LD plots, r2. Populations: CEU, Utah residents with ancestry from northern and western Europe from the
CEPH collection; YRI, Yoruba from Ibadan, Nigeria.
https://doi.org/10.1371/journal.pgen.1006328.g002
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Genetic risk of CAD vs positive selection in BCAS3
The genetic risks of CAD for variants in BCAS3 were positively correlated with an extremely
large candidate adaptive signal in all European and two of three East Asian populations (Fig
1B). For example in CEU, the largest iHS score was 4.85 and highly significant, and was ele-
vated across most of BCAS3 (Fig 2B CEU, spanning introns 1–18 and various LD-blocks, Fig
2C), which matched the approximate trends in CAD log odds giving rise to a highly significant
positive correlation (Fig 2A CEU). In contrast, in YRI there was no detectable selection signal
close to the index SNP (Fig 2B YRI), but weak-moderate signals were present towards the end
of BCAS3 (Fig 2B YRI, introns 18–19, smaller LD-blocks Fig 2C), which also corresponded
with lower CAD log odds (Fig 2B, YRI) thus giving rise to a significant negative correlation in
Fig 2A.
Genetic risk of CAD vs positive selection in PHACTR1
For all European populations, PHACTR1 (see CEU example, Fig 3A) selection peaks were typi-
cally located within regions of consistently lower CAD log odds (Fig 3B). This contrasted with
Fig 3. Quantitative links between coronary artery disease risk and selection signals in PHACTR1. A.
Correlation between selection signals (iHS) and coronary artery disease (CAD) log odds genetic risk (ln(OR)),
both represented as absolute values. Red line/upper right value, β from mixed effects regression. B. Base pair
positional comparison of selection signals and CAD genetic risk across PHACTR1. Blue points, CAD log odds
values; grey-orange or non-significant-significant points, iHS scores. Horizontal bar shows PHACTR1 gene (and
intron) spans and location of index SNP if present. C. LD plots, r2. Populations: CEU, Utah residents with ancestry
from northern and western Europe from the CEPH collection; GIH, Gujarati Indians in Houston, TX, USA.
https://doi.org/10.1371/journal.pgen.1006328.g003
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most other non-European populations where the highest candidate selection peaks were
located within regions with elevated CAD log odds (including the index CAD SNP
rs12526453, intron 4). The largest selection peak in GIH (Fig 3B) overlapped the CAD log
odds peak in PHACTR1 giving rise to the strong positive association seen in Fig 3A. The two
distinctive selection peaks in both CEU and GIH were separated by different LD-blocks (Fig
3C), suggesting that these may have developed independently within PHACTR1. Interestingly,
the negative association found for the MKK population was due to the location of the selection
peaks more closely matching those of the European populations in intron 11 (S2 Fig).
Enrichment of gene regulatory variants under selection at CAD loci
To establish whether variants with evidence of selection in CAD genes also showed evidence
of function, we performed an eQTL scan in 8 HapMap3 populations with matched LCL gene
expression. We compared all SNPs in each CAD locus against expression for each focal gene
within each population.
We found that SNPs with significant integrated Haplotype Scores (iHS) were often also
involved in gene regulation, compared to SNPs with non-significant selection scores (Fig 4,
Kolmogorov-Smirnov test p value<0.001). To assess which biological pathways were enriched
for the highest-ranked genes according to Fig 1B, i.e. those where selection scores were most
closely associated with CAD log odds genetic risk, we included the top 10 genes into the
Enrichr analysis tool [49] and found that these genes are especially enriched in pathways
related to metabolism, focal adhesion and transport of glucose and other sugars. More interest-
ingly, we found connections to reproductive phenotypes in the associations of these genes with
pathways, ontologies, cell types and transcription factors. For example, we found links to ovar-
ian steroidogenesis and genes expressed in specific cell types and tissues including the ovary,
endometrium and uterus (see S1 Table for Enrichr outputs).
Enrichment of CAD loci for lifetime reproductive outcomes and
antagonistic effects
To test whether CAD genes are directly associated with human lifetime reproductive success
(LRS or total number of children born across reproductive lifetimes), a prerequisite for responses
to selection, we examined their association with LRS for women in the Framingham Heart Study
(FHS). Out of the 76 CAD genes (representing 20,254 SNPs in total; a minimum, average and
maximum of 18, 266 and 2121 SNPs tested per gene, respectively), 51 genes contained SNPs that
were significantly nominally associated with LRS (p<0.05), 30 genes contained SNPs associated
at p<0.01 and 12 genes contained SNPs associated at p<0.001, based on both nominal p values
from FaST-LMM and permuted p values (see S2 Table). For example, the most significant associ-
ations per gene included rs56152906 in PPAP2B (p = 5.23E-06, permuted p<0.0001), rs7896502
in LIPA (p = 0.0002, permuted p = 0.0001) and rs2479409 in PCSK9 (p = 0.0003, permuted
p = 0.0001) including a further 9 (COL4A2, FLT1, HDAC9, KSR2, LPA, MIA3, PDGFD, PLG,
SMAD3) genes with significant LRS associations at permuted p<0.001. The two previous studies
that have investigated genome-wide SNP associations with LRS found associations with similar
levels of evidence to our study. For example, the leading SNP in Kosova et al. [50] for completed
family size was rs10966811 with p = 5.57E-06. The top two leading SNPs in Aschebrook-Kilfoy
et al. [51] for LRS were rs10009124 (p = 7.65E-08) and rs1105228 (p = 2.16E-06).
When we considered these associations using fastBAT that combines SNP associations
within a gene (accounting for LD-redundancy) into single gene-level p value, similar results
were obtained with 8 genes significantly associated with LRS (e.g. PPAP2B, p = 0.0004, per-
muted p = 0.001, SMAD3, p = 0.0061, permuted p = 0.007, MIA3, p = 0.008, see S2 Table).
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To test the null hypothesis that CAD variation is no more significantly associated with LRS
than is variation in the rest of the genome, we used a permutation approach. We sampled 20,254
non-CAD related SNPs (matched within MAF bins to the CAD SNPs) randomly (without replace-
ment) across the genome 100 times. The permuted p value was based on the number of times each
random sample of 20,254 non-CAD SNPs shared significantly more associations with LRS than
did the 20,254 CAD SNPs. The total sample of randomly selected SNPs (n = 2,025,400) was also
compared against the 20,254 CAD SNPs with a Kolmogorov-Smirnov (K-S) test. We found that
CAD genetic variation was significantly (p = 9.49E-08 and p = 1.90E-07 based on one- and two-
sided K-S tests, respectively; permuted p<0.01) more enriched for LRS compared to the rest of the
genome (see S2 Table for other fitness-related traits), providing strong evidence in the FHS for
shared fitness effects at CAD loci. This was also the case when we tested this at the gene-level using
fastBAT results (permuted p = 0.026, S2 Table).
To test whether effects between CAD loci and LRS were antagonistic, we cross-referenced the
genome-wide significant index SNPs for CAD from Nikpay [40] with significant SNPs for LRS
from the FaST-LMM analysis. Of the 56 CAD index SNPs in Nikpay [40], 53 were genotyped or
imputed in the FHS to a high confidence. In FHS, six of those SNPs (11.3%) were significantly
associated with LRS (FaST-LMM p< 0.05), with 5 out of those 6 antagonistic, i.e. the allele that
increases LRS also increases risk for CAD (see S3 Table). For example, in FLT1, rs9319428-A sig-
nificantly increases both LRS (ß = 0.041, p = 0.0143) and CAD risk (ß = 0.039, p = 7.13E-05),
and similarly, rs2048327-C in LPA significantly increases both LRS (ß = 0.041, p = 0.00894) and
CAD risk (ß = 0.057, p = 2.46E-09). This suggests that antagonistic effects occur in some loci,
but the power to detect and define this for smaller effect variants on LRS is limited in the FHS
(e.g. see S3 Fig for power estimates). Compared to the CARDIoGRAMplusC4D study [40]
Fig 4. Comparing positive selection with gene regulation. Summary distribution of permuted eQTL p
values for SNPs with (left) or without (right) a significant selection signal. SNPs with a significant selection
signal (iHS) were chosen by taking the largest significant positive selection signal (if one was present) within
each gene-population combination. The same number of SNPs without a significant selection signal were also
randomly drawn across all gene-population combinations for comparison. These SNPs were used in an eQTL
analysis where they were regressed (including gender as a covariate) against their associated gene probe’s
expression.
https://doi.org/10.1371/journal.pgen.1006328.g004
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where the 56 genome-wide significant CAD index SNPs were obtained using a meta-sample of
~184,000 individuals, SNP effects on LRS were based on 1,579 women from the FHS. Given that
power to detect small effects (i.e. |ß|<~0.3–0.4 or OR<~1.2–1.3) in these studies is poor when n
is small (i.e. ~1000 individuals [52]) suggests that larger samples of women and men with com-
pleted reproduction are needed to test for antagonistic effects comprehensively to avoid false
negatives.
We further tested whether SNPs are associated with both LRS and CAD due to potential
confounding effects rather than antagonistic pleiotropy, i.e. confounding effects would occur
if CAD SNPs influence LRS, which in turn cause significant changes in CAD risk due to physi-
ological, hormonal or social changes related to childbearing/rearing. We tested the association
between CAD SNPs and CAD in FHS females, stratified by LRS (see S3 Fig for full analysis).
We found no significant effect of LRS modifying SNP effects on CAD (see S3 Fig), which sup-
ports the antagonistic pleiotropy hypothesis, however we caution that larger, better powered
studies may show some level of attenuation.
Extending this investigation to understand why CAD genes are significantly enriched for
LRS, i.e. what possible underlying reproductive processes are contributing, we performed an
extensive systematic literature search on the 40 top-ranked genes in Fig 1 and a random set of
20 non-CAD genes. While gene set enrichment had been performed (above) suggesting some
connections to reproductive phenotypes, such tools cannot capture the full range of possible
effects on multiple fitness traits, some that are themselves rarely tested in other mammalian
(non-human) species due to ethical limitations. We found evidence for direct links between
CAD genes and fitness (S4 and S5 Tables) including genes associated with reproductive
(PPAP2B, [53]) or twinning (SMAD3, [54]) capacity and number of offspring produced (e.g.
KIAA1462, [55], SLC22A5, [56]). PHACTR1, LPL, SMAD3, ABO and SLC22A5 may contribute
to reproductive timing (menarche, menopause) in women [57–59] and animals [60]. Expres-
sion of PHACTR1 [61], KCNK5 [62], MRAS and ADAMST7 [63] appear to regulate lactation
capacity. Some gene deficiencies also cause pregnancy loss (e.g. LDLR, [64], COL4A2, [65]).
Evidence for other pleiotropic links related to fitness included 25 genes that shared links with
traits expressed during pregnancy (S4 and S5 Tables), i.e. variation that can negatively influ-
ence the health and survival outcomes of both the fetus and mother [66]. For example, a vari-
ant of CDKN2B-AS1 significantly contributes to risk of fetal growth restriction [67], both FLT1
[68] and LPL [69] are significantly differentially expressed in placental tissues from pregnan-
cies with intrauterine growth restriction (IUGR), and preeclampsia and LDLR-deficient mice
had litters with significant IUGR [70]. A further 29 and 19 genes were linked to traits that can
directly influence female and male fertility, respectively (13 influence both) (S4 and S5 Tables).
For example, BCAS3 and PHACTR1 are highly expressed during human embryogenesis [71,
72], SWAP70 is intensely expressed at the site of implantation [73], and PHACTR1 may play a
role in receptivity to implantation [74]. For ABCG8 and KSR2, animal models provide further
support as gene expression deficiency can cause infertility in females (ABCG8, [75]) and males
(KSR2, [76]).
Pleiotropic connections were also apparent in the classification of specific disorders or from
studies investigating single-gene effects. For example, women with polycystic ovarian syndrome
(PCOS) have higher rates of infertility due to ovulation failure and modified cardiovascular dis-
ease risk factors (i.e. diabetes, obesity, hypertension [77]). While reduced fecundity associated
with PCOS might suggest it would not fit the model of antagonistic pleiotropy, some hypothesize
that it is an ancient disorder and may have provided a rearing advantage in ancestral food-lim-
ited environments [78]. A number of CAD genes in this study (e.g. PHACTR1, LPL, PDGFD,
IL6R, CNNM2) are found differentially expressed in PCOS women [79–83], suggesting possible
links between perturbed embryogenesis and angiogenesis. In males, this can be demonstrated
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with a mutation in SLC22A5 that causes both cardiomyopathy and male infertility due to altered
ability to break down lipids [84, 85]. More generally, many recent studies link altered cholesterol
homeostasis with fertility, which is most apparent in patients suffering from hyperlipidemia or
metabolic syndrome [86, 87].
For the random set of non-CAD genes that were approximately the same size as the top 20
genes in Fig 1, we were only able to find three (out of 20) with at least one potential link with
fitness (S6 Table) using the same systematic literature search further demonstrating the relative
abundance of CAD loci effects on fitness earlier in life.
Discussion
This study identified many candidate adaptive signals suggesting that selection on CAD loci is
much more widespread than previously appreciated (also see S1 Discussion). It has previously
been suggested [12] and demonstrated [88] that selection on gene expression levels has been
an important element of human adaptation in general. We confirm this result for CAD associ-
ated loci. Positive selection signals within CAD loci were more likely than random SNPs to be
associated with gene expression levels in cis (Fig 4).
We found evidence that some of these signals may be a result of selection pressures induced
directly by CAD itself. This finding is important for highlighting genes that may have been
modified directly by selection on disease phenotypes and also for our general understanding of
how quickly human genomes can respond to selection induced by changing environments.
Subsequent fitness and biological process analyses and a thorough literature review demon-
strated that CAD loci are enriched for lifetime reproductive success in women and also linked
to other male and female reproductive phenotypes, which suggests both their potential to
respond to natural selection and their possible role via antagonistic pleiotropy in the reproduc-
tive tradeoffs that would help to explain why CAD is common in modern humans. While the
connection between cardiovascular disease and lifetime parity is not novel (e.g. see [89, 90]), it
is not known whether this connection is due to hormonal, physiological, social or selective
processes. The current study provides the first evidence for a selective and antagonistic
mechanism.
Coronary artery disease-induced changes to human genomes
One of our most interesting findings was the significant association between selection signals
and CAD log odds genetic risk. This approach of integrating genome scans of positive selec-
tion with genome-wide genotype-phenotype data has been promoted previously as a tool to
uncover biologically meaningful selection signals of recent human adaptation [12, 88] but has
rarely been applied. Among the exceptions, Jarvis et al. [91] found a cluster of selection and
association signals coinciding on chromosome 3 that included genes DOCK3and CISH, which
are known to affect height in Europeans.
For highly-ranked genes (according to the number of significant associations present
within the 12 populations) in Fig 1B such as BCAS3, CNNM2, TEX41, SMG6 and PHACTR1,
the consistent overlap between selection and genetic risk of CAD suggests that many of these
may have been modified by CAD-linked selective pressures. If so, then two conditions must
have been met. Firstly, CAD was present for long enough to be involved in these genetic alter-
ations, an evolutionary process which generally takes thousands of years. Indeed, precursors of
CAD (i.e. atherosclerosis) are detectable in very early civilizations [47]. Secondly, the effects of
CAD were directly or indirectly expressed during the reproductive period and trait variation
was under natural selection due to its effects on reproductive success.
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It is only possible for natural selection to directly act on CAD if those outcomes modify
individual fitness relative to others in the same population. As outlined in the introduction,
this is possible as CAD outcomes (i.e. myocardial infarction) do occur in young adults. How-
ever, early-life CAD outcomes are relatively rare, suggesting selection is more likely to operate
indirectly on CAD via its risk factors (or other pleiotropically linked traits, discussed below),
which provides a more likely explanation for the close associations we found between positive
selection and genetic risk. Supporting this, phenotypic selection has been found operating on
CAD risk factors [41], suggesting that these selection pressures are still present in modern
humans.
Some genes had large signals of selection but showed weak or no consistent overlap with
CAD genetic risk. For example HDAC9 (Histone Deacetylase 9) shows extensive evidence for
having undergone recent selection within most populations, especially those of European or
Mexican decent, but little or no overlap with CAD risk was evident in most populations. This
suggests positive selection has operated on this gene due to its effects on a trait unrelated to
CAD, which may not be surprising given HDAC9’s broad biological roles (as a transcriptional
regulator, cell-cycle progression) and association with other very different phenotypes includ-
ing ulcerative colitis [92] and psychiatric disorders [93]. This further demonstrates that this
approach is useful for separating candidate selection signals important for the disease or phe-
notype of interest from those that aren’t.
Pleiotropic effects that establish the genetic foundations of tradeoffs
We found direct evidence in the Framingham Heart Study for shared fitness effects at CAD loci,
which were specifically significantly enriched for their effects on female lifetime reproductive
success relative to the rest of the genome. This novel finding shows a connection between direct
fitness and later disease expressed through CAD loci. An extensive literature review supported
this conclusion. All 40 CAD genes from Fig 1 shared at least one (often more) connection with
fitness (S4 and S5 Tables). Some appear to directly influence fitness (offspring number, age at
menarche, menopause, survival), while many were associated with early-life reproductive traits
that are likely to correlate with fitness, including variation in ability to fertilize/conceive or fetal
growth, development and survival. This suggests further pleiotropic links between CAD and
early-life fitness-related traits. Directly testing for antagonistic effects between fitness and CAD,
we found evidence at specific loci for the leading CAD index SNPs, where the allele that signifi-
cantly increased LRS also significantly increased CAD. We further found no evidence that this
link between CAD and LRS was due to confounding (e.g. physiological, hormonal) effects of
LRS on CAD risk. While this is promising, the Framingham study is limited in its power to
detect small fitness and CAD effects; better powered studies may yet be needed to definitively
establish antagonistic effects at all loci. Fitness traits collected on genotyped populations are cur-
rently rare, but this is likely to change as more biobank-scale studies come online.
To facilitate interpretation of selection occurring on early-life traits or CAD phenotypic risk
factors that share pleiotropic connections and possible evolutionary tradeoffs with coronary
artery disease, we present a conceptual figure (Fig 5). These pleiotropic effects are important
because many of them affect traits expressed early in life, some extremely early in life. Any allele
that increases reproductive performance enough early in life to more than compensate for a loss
of associated fitness late in life will be selected [42]. Such a mechanism has been recently sug-
gested to help explain the maintenance of polymorphic disease alleles in modern human popu-
lations [94]. While such tradeoffs have been previously tested for in humans using genotypes,
LRS and lifespan (e.g. [95]), there is not yet much evidence that such a mechanism influences
human disease. A 2017 study by Rodrı´guez et al. [96] that used an indirect measure of fitness
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provides support for antagonistic pleiotropy acting on general early health and later life disease.
Our study demonstrates that CAD genes are significantly and directly enriched for fitness with
evidence that some of the leading CAD effect SNPs share an antagonistic relationship with fit-
ness through significant positive effects on LRS. This provides support for such a mechanism
influencing CAD and may help to explain our vulnerability to this disease.
Study limitations
There are also some limitations to our approach. We utilized CAD genetic risk estimated from
a meta-analysis based on predominantly European (77%) with smaller contributions from
south/east Asian (19%), Hispanic and African American (~4%) ancestry [40]. Genetic risk var-
iation for CAD might be different in the un-represented (i.e. Mexican) or less-represented (i.e.
African) populations in this meta-analysis. If that were the case, it would reduce the usefulness
of comparing selection and risk estimates in those populations. We also saw fewer significant
selection-risk associations in the African populations (Fig 1B), however this may be due to
selection signals in the African populations being less obvious than those in East Asian and
Fig 5. Conceptual figure of potential evolutionary tradeoffs between coronary artery disease (CAD) burden and other
phenotypes as a consequence of antagonistic pleiotropy (AP) [42]. As a simple example, AP describes gene effect on
two traits (pleiotropy) that oppositely (antagonistic) affect individual fitness at different ages. Selection on that gene conferring a
fitness advantage and disadvantage at different ages depends on the size and timing of the effects. An advantage during the
ages with the highest probability of reproduction (between~20–45 years of age in humans) would increase fitness (lifetime
reproductive success) more than a similarly sized disadvantage at later ages would decrease it. This concept is part of the well-
known evolutionary theory of ageing, which describes tradeoffs in energy invested into growth, reproduction and survival [97].
In the figure above, intense natural selection occurring on CAD loci as a result of fitness advantages (+ signs, red text callout
box 1.) conferred by genetically correlated risk factors (‘CAD risk factors’ box) or early-life traits (‘early-life traits’ box) trades off
with the deleterious effects of these genes on fitness (i.e. CAD burden) later in life (- sign, red text callout box 2.) where the
intensity of selection is weak. This occurs because of the negative relationship between genetic effects on early vs late-life
traits (- sign, red text callout box 3.), which could help explain the high prevalence and maintenance of CAD in modern human
populations. Over shorter timescales, lifetime probability of CAD is modified by a combination of genetic and environmental risk
factors (e.g. [98]). There is evidence that such antagonistic effects have operated on CAD loci given: significant associations
between CAD genetic risk and selection found (Figs 1 and 2); CAD genes are significantly enriched for lifetime reproductive
success (S2 Table) and may also effect other early-life traits known to modify fitness (S4 Table); suggestive evidence was
found for an antagonistic relationship between CAD and LRS (S3 Table); phenotypic selection has been found operating on
CAD phenotypic risk factors [41].
https://doi.org/10.1371/journal.pgen.1006328.g005
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European populations, perhaps due to lesser linkage disequilibrium, as is consistent with
results from previous studies [99]. Calculating disease risk and selection variation from popu-
lations within the same ancestral group might help resolve this, however it only represents a
potential shortcoming for our cross-population analyses and not observations of antagonistic
pleiotropy.
Summary
In this study, we found evidence that natural selection has recently operated on CAD associ-
ated variation. By comparing positive selection variation with genetic risk variation at known
loci underlying CAD, we were able to identify and prioritize genes that have been the most
likely targets of selection related to this disease across diverse human populations. That selec-
tion signals and the direction of selection-risk relationships varied among some populations
suggests that CAD-driven selection has operated differently in these populations and thus that
these populations might respond differently to similar heart disease prevention strategies. The
pleiotropic effects that genes associated with CAD have on traits associated with reproduction
that are expressed early in life strongly suggests some of the evolutionary reasons for the exis-
tence of human vulnerability to CAD.
Methods
Defining loci linked to coronary artery disease
We started with the 56 lead index SNPs from Supplementary Table 5 in Nikpay et al. [40] cor-
responding to 56 CAD loci. When the index SNP was genic, all SNPs within that gene were
extracted (using NCBI’s dbSNP) including directly adjacent intergenic SNPs ±5000bp from
untranslated regions (UTR) in LD r2>0.7 (with any respective genic SNP). When the index
SNP was intergenic, that SNP and other directly adjacent SNPs ±5000bp and in LD>0.7 (with
the index SNP) were extracted and combined with SNPs from the respective linked gene listed
in Nikpay including SNPs ±5000bp from UTR regions in LD r2>0.7 with that gene. This
resulted in SNP lists for 56 genes. To further explore other genes not directly connected with
lead index SNPs, but that were within the CAD loci identified by the two most recent CARDI-
oGRAMplusC4D studies–including Deloukas et al. [39] (i.e. 46 loci and 61 genes listed in their
Tables 1–2) and Nikpay et al. [40] (i.e. 10 loci and 15 genes listed in their Table 1)—we ex-
tracted SNPs within each of those genes (plus SNPs ±5000bp from UTR regions in LD r2>0.7
with that gene). This resulted in SNP lists for a further 20 genes, bringing the total number of
candidate genes for CAD to 76.
The per-SNP log odds (ln(OR)) values for the 76 genes were obtained for the additive
model from Nikpay et al. [40] available at http://www.cardiogramplusc4d.org/downloads and
used in the analysis described below.
Preparation of HapMap3 samples
Genotype data (1,457,897 SNPs, 1,478 individuals) were downloaded for 11 HapMap Phase
3 (release 3) populations (http://www.hapmap.org [100]) including: Yoruba from Ibadan,
Nigeria (YRI), Maasai in Kinyawa, Kenya (MKK), Luhya in Webuye, Kenya (LWK), African
ancestry in Southwest USA (ASW), Utah residents with ancestry from northern and western
Europe from the CEPH collection (CEU), Tuscans in Italy (TSI), Japanese from Tokyo (JPT),
Han Chinese from Beijing (CHB), Chinese in Metropolitan Denver, Colorado (CHD), Guja-
rati Indians in Houston, TX, USA (GIH), and Mexican ancestry in Los Angeles, CA, USA
(MEX). We also included another HapMap3 population, the Finnish in Finland (FIN) sample
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(ftp://ftp.fimm.fi/pub/FIN_HAPMAP3 [101]). These data had already been pre-filtered, i.e.
SNPs were excluded that were monomorphic, call rate< 95%, MAF<0.01, Hardy-Weinberg
equilibrium p<1x10-6.
Before phasing and imputation, we performed a divergent ancestry check with flashpca
[102] to check accuracy of population assignments, converted SNP data from build 36 to 37
with UCSC LiftOver (https://genome.ucsc.edu/cgi-bin/hgLiftOver), checked strand alignment
in Plink v1.9 [103] to ensure all genotypes were reported on the forward strand, and kept only
autosomal SNPs. To speed up imputation, data were first pre-phased with Shapeit v2 [104]
using the duoHMM option that combines pedigree information to improve phasing and
default values for window size (2Mb), per-SNP conditioning sates (100), effective population
size (n = 15000) and genetic maps from the 1000 Genomes Phase 3 b37 reference panel (ftp.
1000genomes.ebi.ac.uk/vol1/ftp/release/20130502/).
Phased data were imputed in 5 Mb chunks across each chromosome with Impute v2 [105].
We then removed any multiallelic SNPs (insertions, deletions etc) from the imputed data and
excluded SNPs with call rate< 95%, HWE p<1x10-6 and MAF<1%. The final dataset was
then phased with Shapeit v2, and alleles were converted to ancestral and derived states using
python script. Ancestral allele states came from 1000 Genomes Project FASTA files and
derived 6-primate (human, gorilla, orangutan, chimp, macaque, marmoset) Enredo-Pecan-
Ortheus alignment [106] from the Ensembl Compara 59 database [107].
Estimating signatures of recent selection
Integrated Haplotype Score (iHS): Using the package rehh [108] in R version 3.1.3, per SNP iHS
scores were calculated within each population (after excluding non-founders) using methods
described previously [9]. iHS could not be calculated for SNPs without an ancestral state, or
whose population minor allele frequency is<5%, or for some SNPs that are close to chromo-
some ends or large regions without SNPs [9]. Rehh was also used to standardize (mean 0, vari-
ance 1) iHS values empirically to the distribution of available genome-wide SNPs with similar
derived allele frequencies. For analyses in the main text, we considered a SNP to have a candi-
date selection signal if it had an absolute iHS score> 2, a permuted p value<0.05, and was
within a ‘cluster’ of SNPs that also had elevated iHS scores. Although permuting p values is
computationally more intensive, it provides more flexibility to detect smaller selection signals
that may be incorrectly classified with the more stringent Bonferroni correction that is often
applied to these estimates. For the analyses described below, even though we only used iHS
estimates for the SNPs defined in the CAD genes (and additional SNPs for permutation pur-
poses), we calculated per-SNP iHS scores genome-wide (rather than locally, i.e. within 1MB
regions around focal SNPs), for this provides more accurate estimates because final adjust-
ments are made relative to other genome-wide SNPs of similar sized derived allele frequency
classes. P values for iHS scores were permuted based on comparison of nominal p values
against 10000 randomly selected estimates from within the same derived allele frequency
classes.
Comparing CAD genetic risk and quantitative selection signals
We first tested the null hypothesis that there is no association between CAD genetic risk and
signals of positive selection for CAD genes. For each gene within each population, we used a
mixed effects linear model to regress SNP-based estimates of CAD log odds (ln(OR)) genetic
risk against selection scores (iHS) resulting in 912 separate regressions. To account for LD
structure (and potential confounding of highly correlated SNPs) within each gene, we also
included the first eigenvector derived from an LD matrix of correlations (r2) between SNPs
Selection and antagonistic pleiotropy on coronary artery disease loci
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1006328 June 22, 2017 16 / 27
within each gene as a random effect. We chose to model LD structure with mixed-effects mod-
els rather than LD-prune because for many genes, the SNP samples would have been too small
for regression analyses. Also, it would be very difficult to properly capture both selection and
the CAD log odds peaks needed to compare these variables. We did however investigate alter-
native models to validate our approach (i.e. running the same models without the LD structure
variable; using smaller multiple LD-pruned subsets of SNPs per gene) with consistent results
suggesting our approach was largely robust to LD effects and likelihood of false positive associ-
ations. We accounted for multiple testing by permuting p values for each regression based on
comparing each nominal p value against 10000 permuted p values derived from shuffling iHS
scores.
Genes were then ranked based on the number of significant associations summed across
the 12 populations. The 40 genes with at least four or more significant associations are shown
in Fig 1B. To illustrate the positional architecture of these selection-risk associations, plots for
selected highly-ranked genes are shown in Figs 1 and 2. By demonstrating how CAD genetic
risk peaks and valleys correspond to variation in the magnitude of selection scores (iHS), this
allowed visual assessment of potential modifications made to the phenotype-genotype map by
selective pressures imposed directly or indirectly by CAD. It also helped us localize selection
peaks within genes and compare them between populations. Similar peaks suggested similar
selection and different peaks suggested local adaptation. This way of presenting the results also
allowed us to detect the smaller adaptive shifts in allele frequencies typically expected to under-
lie selection on polygenic traits.
We then tested a second null hypothesis: that the selection-risk associations using the CAD
genes are not unique compared to non-CAD associated loci. For each of the 76 CAD genes,
we randomly (without replacement) chose 100 genes of similar length across the genome and
performed the same mixed effects regression procedure described above for each gene by pop-
ulation combination using both CAD log odds values from Nikpay et al. [40], iHS scores esti-
mated from the SNP data, and the first LD eigenvector from SNPs within a gene. Permuted p
values were derived by comparing the nominal p value for each CAD gene against the 100 null
distribution p values from the non-CAD associated genes. Results are shown in Fig 1C.
Identifying functional targets of selection
To examine whether candidate adaptive signals within each gene corresponded to a gene’s reg-
ulatory variation, we regressed SNPs within focal genes and gender against that gene’s probe
expression levels, which had previously been quantified in lymphoblastoid cell lines from cir-
culating peripheral blood using Illumina’s Human-6 v2 Expression BeadChip for eight of the
12 populations [109]. Given gene expression in peripheral blood is known to be an important
marker for cardiovascular disease, we therefore might expect this cell type a good candidate to
search for association between selection signals and regulatory variants important for these
genes. The raw gene microarray expression data had previously been normalized on a log2
scale using quantile normalization for replicates of a single individual then median norma-
lization for each population [109]. P values for each SNP-probe association were permuted
using 10000 permutations by randomly shuffling gene probes expression. P values were then
extracted for the most significant iHS score for each gene-population combination and com-
pared to the same number of p values randomly drawn from different LD blocks underlying
SNPs with non-significant iHS scores across each gene-population combination. A Kolmogo-
rov-Smirnov test was used to compare the distribution of p values from each. To examine
what biological processes were associated with the top ranked genes from Fig 1, we uploaded
the top 10 genes into Enrichr (http://amp.pharm.mssm.edu/Enrichr/) to define associated
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pathways (i.e. KEGG 2016, kegg.jp/kegg), ontologies (MGI Mammalian phenotypes,
informatics.jax.org), cell types (Cancer cell line Encyclopedia, broadinstitute.org/ccle) and
transcription factors (ChEA 2015, amp.pharm.mssm.edu/lib/chea.jsp).
Testing for fitness effects of CAD loci
We tested whether CAD SNPs were directly associated with human fitness. For a trait to
evolve, this is one of the main prerequisites, but it also helps demonstrate whether alleles that
influence disease also influence reproduction, which in the case of CAD suggests there may be
antagonistic trade-offs between early versus late life.
We used the Framingham Heart Study dataset because it has completed reproductive out-
comes (lifetime reproductive success (LRS) or number of children ever born), genotypes,
pedigree data, cardiovascular outcomes and demographic and socioeconomic data. LRS was
derived from clinical questionnaires and further validated with pedigree data. We did not
include other datasets for validation here, as it is extremely hard to find others that include all
these variables. There were 1,579 women from the Original and Offspring cohorts who had
genotypes and all phenotypes available also after excluding non-founders. FHS 500k Affyme-
trix genotypes were 1000-Genomes imputed using the same pipeline described above bringing
the total number of SNPs available (at MAF>1%) to 7,486,901. LRS was adjusted to deal with
secular demographic change where data was broken into six groups based on year women
were born and divided by the mean reproductive success of women in that group (same as
described in [41]).
We examined the association of all SNPs available in the FHS for the 76 CAD genes (20,254
SNPs) with LRS using linear mixed models implemented in FaST-LMM [110] that account for
potential confounding effects of genetic similarity by including a k-spectral decomposition
variable derived from the realized relationship matrix (RRM) of an LD-pruned subset of SNPs.
SNPs used for RRM were not in LD with CAD SNPs to avoid proximal contamination. Factors
that may affect LRS—education, smoking status, whether the person was born in the US, and
estrogen usage (hormone therapy or contraceptive use)—were included as covariates. Permu-
tations with 10,000 iterations were also run for each SNP in order to validate nominal p values
obtained directly from FaST-LMM, where permuted p values were based on the number of
times nominal p values for 10,000 randomly chosen SNPs (within a similar MAF bin) were
greater than the target SNP nominal p value. Bonferroni and FDR adjustment was also applied
to p values based on 20,254 tests.
To test the null hypothesis that CAD SNPs are collectively no more enriched for fitness
compared to non-CAD SNPs, we randomly sampled without replacement 20,254 non-CAD
SNPs (matched within MAF bins to the CAD-SNP sample) 100 times. The permuted p value
was based on the number of times (out of 100) that the number of significant p values in the
random sample exceeded that for the CAD SNP sample. We also compared the distribution of
p values between all randomly chosen SNPs (2,025,400) from this analysis to the 20,254 CAD
SNPs with a Kolmogorov-Smirnov test. One- and two-sided tests were run. The one-sided test
specifically tested whether the distribution of p values for CAD SNPs was stochastically larger
compared to non-CAD SNPs.
We then used fastBAT [111] to test whether CAD is enriched for fitness at the gene-level.
fastBAT combines SNP-based summary-level data from GWAS and LD reference data to give
locus-based estimates of association. We also ran 100 permutations for each of the 76 genes in
order to estimate a permuted p value for each locus. Permuted p values were based on the
number of times p values for the 100 randomly chosen similarly-sized genes were greater than
that for each CAD gene. We also tested whether CAD genes were collectively more enriched
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for fitness at the gene-level, relative to non-CAD genes. We randomly chose 76 non-CAD
genes of similar size with 300 permutations (sampling without replacement) and asked how
many times the number of p values for the non-CAD genes exceeded that of the CAD genes.
Other traits that may influence fitness were also tested (using the same analysis/permuta-
tion tests as above) for FHS women including age at first and last birth, interbirth interval,
menarche and menopause. Menarche and menopause were derived from questionnaires,
while birth timing/spacing were estimated from pedigrees. We did not consider reproductive
outcomes for men as that data was only available from pedigrees, which is less reliable than
clinical records. Age at first and last birth and interbirth interval were also adjusted for secular
demographic changes (same as above).
Alternative simplified models for LRS, AFB and ALB were run in FaST-LMM where fitness
measures were not adjusted for temporal effects and no covariates were included. This boosted
sample sizes (S2 Table) due to avoiding missing values associated with covariates, however
results were largely comparable (S2 Table) suggesting no power gain from unadjusted models.
Testing for antagonistic effects between fitness and CAD
We only tested for antagonistic effects for LRS as that is the most direct measure of fitness and
was the only fitness trait where CAD SNPs were significantly and consistently enriched across
(un)adjusted models (S2 Table). To assess whether antagonistic effects were present between
LRS and CAD, genome-wide significant CAD index SNPs were taken from Nikpay et al. [40]
and cross-referenced with significant LRS SNPs from the FaST-LMM regression results. In an
extended analysis (results not shown), we also included any SNP in high-LD (r2> = 0.8) and
proximal (±1MB) to the index SNP to boost the number of SNPs available for comparison:
results were virtually identical for the significance of LRS and CAD effects and the consistency
of antagonistic effects. An antagonistic effect was defined as an allele that significantly in-
creased LRS and significantly increased CAD risk. We also tested whether CAD SNPs were
associated with both LRS and CAD due to other confounding (rather than pleiotropic) effects
(see S3 Fig for methods and findings).
Supporting information
S1 Fig. Association of coronary artery disease (CAD) risk and genomic signatures of selec-
tion in 12 worldwide populations. All 76 genes are shown ranked according to Fig 1B. Boxes
show magnitude and significance of largest positive selection signal (integrated haplotype
score, iHS) within each gene-population combination. P values (circles within squares) were
obtained from 10000 permutations. Bonferroni corrected p value limit also shown (α = 0.05/
76 = 0.000657) with closed circles. Populations. Grouped by common ancestry, African
(ASW, African ancestry in Southwest USA; MKK, Maasai in Kinyawa, Kenya; YRI, Yoruba
from Ibadan, Nigeria; LWK, Luhya in Webuye, Kenya), East- Asian (CHB, Han Chinese sub-
jects from Beijing; CHD, Chinese in Metropolitan Denver, Colorado; JPT, Japanese subjects
from Tokyo), European (CEU, Utah residents with ancestry from northern and western
Europe from the CEPH collection; TSI, Tuscans in Italy; FIN, Finnish in Finland), GIH (Guja-
rati Indians in Houston, TX, USA), MEX (Mexican ancestry in Los Angeles, CA, USA).
(PDF)
S2 Fig. Comparing cross-population candidate selection signals in PHACTR1. Per-SNP
integrated Haplotype Scores (iHS) plotted by chromosome position within PHACTR1 (includ-
ing LD plots below each) for 12 worldwide populations. Permuted p value significance for
each score coded by color (grey, non-significant; orange, p< 0.05). Red dashed line indicates
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position of index SNP for PHACTR1. Grey columns in background represent intron spans.
Populations are clustered by common ancestry, African (ASW, African ancestry in Southwest
USA; MKK, Maasai in Kinyawa, Kenya; YRI, Yoruba from Ibadan, Nigeria; LWK, Luhya in
Webuye, Kenya), East-Asian (CHB, Han Chinese subjects from Beijing; CHD, Chinese in Met-
ropolitan Denver, Colorado; JPT, Japanese subjects from Tokyo), European (CEU, Utah resi-
dents with ancestry from northern and western Europe from the CEPH collection; TSI,
Tuscans in Italy; FIN, Finnish in Finland), GIH (Gujarati Indians in Houston, TX, USA),
MEX (Mexican ancestry in Los Angeles, CA, USA).
(PDF)
S3 Fig. Testing whether CAD SNPs are associated with both LRS and CAD due to pleiot-
ropy or confounding effects. Confounding effects would occur if coronary artery disease
(CAD) SNPs modestly affected lifetime reproductive success (LRS), which in turn caused sig-
nificant changes in CAD risk due to physiological, hormonal or social changes related to child-
bearing/rearing [1, 2]. If this was the case, we would expect that the effect of CAD SNPs on
CAD should diminish when adjusting for LRS; in the case of pleiotropy, it would not. Grey
dots represent regression coefficients (β) for index SNPs on CAD outcomes with (model 2) or
without (model 1) stratifying for LRS. β’s are exponeniated coefficients from Cox proportional
hazard models that were also adjusted for other potentially confounding effects on CAD (see
methods below).
(PDF)
S1 Table. Selected Enrichr analysis outputs for top 10-ranked CAD genes with highest
genetic risk-selection associations from Fig 1B. Enrichr outputs includes KEGG 2016 Path-
ways (http://www.kegg.jp/kegg/download/), MGI Mammalian Phenotype Level 3 (http://
www.informatics.jax.org/), Cancer Cell Line Encyclopaedia (http://portals.broadinstitute.org/
ccle/data/browseData), and ChEA 2015 (http://amp.pharm.mssm.edu/lib/cheadownload.jsp).
(PDF)
S2 Table. Testing association of CAD SNPs with human fitness in the Framingham Heart
Study women. First three columns give number of individuals available and used in analyses.
Four FaST-LMM columns provide summary of leading results including leading and highest
ranked SNP(s) (and associated genes). Three fastBAT columns provide leading gene(s). Final
four columns provide statistics for testing the Null hypothesis that CAD variation is no more
enriched for fitness compared to non-CAD variation found genome-wide.
(PDF)
S3 Table. Testing for antagonistic pleiotropy for SNPs with significant effects on lifetime
reproductive success (LRS) and coronary artery disease (CAD). Left table: provides statistics
for CAD index SNPs derived directly from the CARDIoGRAMplusC4D 1000 Genomes-based
GWAS meta-analysis (see [1] or http://www.cardiogramplusc4d.org/data-downloads/ for fur-
ther details of data and variables). Right table: provides corresponding FaST-LMM regression
statistics of these SNPs on LRS based on Framingham Heart Study women (first six columns),
rows correspond to SNPs in the left table. Last four columns test for antagonistic effects
between CAD and LRS with the last two providing these tests only when the LRS beta was sig-
nificant. This shows that when SNPs with significant effects on both LRS and CAD are consid-
ered, most (5 of 6, or 83%) were antagonistic, i.e. the allele that increases LRS also increases
CAD risk.
(PDF)
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S4 Table. Pleiotropic links between coronary artery disease (CAD) and early- life fitness-
related traits due to shared genetic loci. The table below provides extensive support (143
studies) that antagonistic pleiotropy is likely to be present for CAD genes due to their consis-
tent connections with fitness-related traits expressed early in life. See Fig 5 for discussion and
conceptual overview of these potential effects. Fitness-related traits include fertility potential,
reproductive outcomes, pregnancy outcomes, fetal growth and survival, i.e. affecting the ability
of an organism to reproduce and transfer genes to the next generation. The first 3 columns
give CAD gene rank (no.; based on rank of 40 genes from Fig 1B), name and full name. Col-
umns 4–8 provide key details of each study where CAD genes also contribute to traits that
influence fitness, including what species that was demonstrated in, what biological process or
fitness effects that gene is impacting, what fitness class that effect is likely to impact (e.g. dys-
functional spermatogenesis or embryogenesis will affect male and female fertility, ability to
conceive), what the observed genetic effect or mechanism that gene was associated with.
(PDF)
S5 Table. Summary of types of pleiotropic connections between coronary artery disease
(CAD) and fitness-related traits. Counts are based on S1 Table, ‘fitness class’ column. Most
fitness-related traits were related to female potential fertility (29 of 40 genes had these effects)
and pregnancy outcomes (25 of 40 genes had these effects). Some genes had broad or specific
effects on fitness-related traits. For example, number of fitness classes affected ranged from 6
for ABO (had fitness effects across all classes) to 1, for example CNNM2 (evidence for fitness
effects in pregnancy outcomes class).
(PDF)
S6 Table. Pleiotropic links between randomly chosen genes and early-life fitness-related
traits. Fitness-related traits include fertility potential, reproductive outcomes, pregnancy
outcomes, fetal growth and survival, i.e. affecting the ability of an organism to reproduce
and transfer genes to the next generation. The first column gives coronary artery disease
(CAD) gene (first 20 of 40 CAD genes from Fig 1B/S1 Table). Columns 2–3 give name
(abbreviated, full) of randomly chosen genes matched for approximate length for each CAD
gene. Columns 4–8 provide key details of each study where random genes also contribute to
traits that influence fitness, including what species that was demonstrated in, what biologi-
cal process or fitness effects that gene is impacting, what fitness class that effect is likely to
impact (e.g. dysfunctional spermatogenesis or embryogenesis will affect male and female
fertility, ability to conceive), what the observed genetic effect or mechanism that gene was
associated with.
(PDF)
S1 Discussion. Widespread candidate signals of positive selection on CAD loci. Extended
discussion on candidate adaptive signals found on coronary artery disease (CAD) loci in rela-
tion to the polygenic model of selection and previous studies examining genomic selection on
broader cardiovascular disease loci.
(PDF)
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